Review



rat anti‐ng2  (Thermo Fisher)


Bioz Verified Symbol Thermo Fisher is a verified supplier
Bioz Manufacturer Symbol Thermo Fisher manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Thermo Fisher rat anti‐ng2
    Anti‐PD‐L1 treatment elicits increased intramucosal T‐cell infiltration and decreased blood vascular density with proper pericyte coverage. Mice were submucosally injected with 5 × 10 5 AOC3‐LN cells in the left buccal area and intraperitoneally injected with an anti‐PD‐L1 inhibitor (10 mg·kg −1 ) twice a week for 3 weeks. (A–D) Immunofluorescence images showing CD8: representing T‐cells, CD31: representing blood vessels, <t>NG2:</t> representing pericyte coverages, and GLUT1: representing hypoxic condition expression level in the tumor microenvironment. Scale bars, 100 μm. (E–H) Comparisons of CD8: representing T‐cells, CD31: representing blood vessels, NG2: representing pericyte coverages, and GLUT1: representing hypoxic condition expression level between control and anti‐PD‐1‐treated groups; Values are expressed as means ± SD, n = 6 in Control, n = 6 in PD‐L1; Student's T tests were performed between groups and * P < 0.05 versus control. (I) Intratumor VEGF levels were assessed using an ELISA kit; Values are expressed as means ± SD, n = 6 in Control, n = 6 in PD‐L1; Student's T tests were performed between groups and * P < 0.05 versus control. Representative results obtained from three repetitive experiments with the same number of mice. ELISA, enzyme‐linked immunosorbent assay; LN, lymph node; PD, programmed death; VEGF, vascular endothelial growth factor receptor.
    Rat Anti‐Ng2, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rat anti‐ng2/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    rat anti‐ng2 - by Bioz Stars, 2026-03
    90/100 stars

    Images

    1) Product Images from "Immune checkpoint inhibitor monotherapy is sufficient to promote microenvironmental normalization via the type I interferon pathway in PD‐L1 ‐expressing head and neck cancer"

    Article Title: Immune checkpoint inhibitor monotherapy is sufficient to promote microenvironmental normalization via the type I interferon pathway in PD‐L1 ‐expressing head and neck cancer

    Journal: Molecular Oncology

    doi: 10.1002/1878-0261.13633

    Anti‐PD‐L1 treatment elicits increased intramucosal T‐cell infiltration and decreased blood vascular density with proper pericyte coverage. Mice were submucosally injected with 5 × 10 5 AOC3‐LN cells in the left buccal area and intraperitoneally injected with an anti‐PD‐L1 inhibitor (10 mg·kg −1 ) twice a week for 3 weeks. (A–D) Immunofluorescence images showing CD8: representing T‐cells, CD31: representing blood vessels, NG2: representing pericyte coverages, and GLUT1: representing hypoxic condition expression level in the tumor microenvironment. Scale bars, 100 μm. (E–H) Comparisons of CD8: representing T‐cells, CD31: representing blood vessels, NG2: representing pericyte coverages, and GLUT1: representing hypoxic condition expression level between control and anti‐PD‐1‐treated groups; Values are expressed as means ± SD, n = 6 in Control, n = 6 in PD‐L1; Student's T tests were performed between groups and * P < 0.05 versus control. (I) Intratumor VEGF levels were assessed using an ELISA kit; Values are expressed as means ± SD, n = 6 in Control, n = 6 in PD‐L1; Student's T tests were performed between groups and * P < 0.05 versus control. Representative results obtained from three repetitive experiments with the same number of mice. ELISA, enzyme‐linked immunosorbent assay; LN, lymph node; PD, programmed death; VEGF, vascular endothelial growth factor receptor.
    Figure Legend Snippet: Anti‐PD‐L1 treatment elicits increased intramucosal T‐cell infiltration and decreased blood vascular density with proper pericyte coverage. Mice were submucosally injected with 5 × 10 5 AOC3‐LN cells in the left buccal area and intraperitoneally injected with an anti‐PD‐L1 inhibitor (10 mg·kg −1 ) twice a week for 3 weeks. (A–D) Immunofluorescence images showing CD8: representing T‐cells, CD31: representing blood vessels, NG2: representing pericyte coverages, and GLUT1: representing hypoxic condition expression level in the tumor microenvironment. Scale bars, 100 μm. (E–H) Comparisons of CD8: representing T‐cells, CD31: representing blood vessels, NG2: representing pericyte coverages, and GLUT1: representing hypoxic condition expression level between control and anti‐PD‐1‐treated groups; Values are expressed as means ± SD, n = 6 in Control, n = 6 in PD‐L1; Student's T tests were performed between groups and * P < 0.05 versus control. (I) Intratumor VEGF levels were assessed using an ELISA kit; Values are expressed as means ± SD, n = 6 in Control, n = 6 in PD‐L1; Student's T tests were performed between groups and * P < 0.05 versus control. Representative results obtained from three repetitive experiments with the same number of mice. ELISA, enzyme‐linked immunosorbent assay; LN, lymph node; PD, programmed death; VEGF, vascular endothelial growth factor receptor.

    Techniques Used: Injection, Immunofluorescence, Expressing, Control, Enzyme-linked Immunosorbent Assay



    Similar Products

    rat anti ng2 ab  (Miltenyi Biotec)
    93
    Miltenyi Biotec rat anti ng2 ab
    Rat Anti Ng2 Ab, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rat anti ng2 ab/product/Miltenyi Biotec
    Average 93 stars, based on 1 article reviews
    rat anti ng2 ab - by Bioz Stars, 2026-03
    93/100 stars
    		  Buy from Supplier
    rat anti ng2 antibody  (R&D Systems)
    96
    R&D Systems rat anti ng2 antibody
    Rat Anti Ng2 Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rat anti ng2 antibody/product/R&D Systems
    Average 96 stars, based on 1 article reviews
    rat anti ng2 antibody - by Bioz Stars, 2026-03
    96/100 stars
    		  Buy from Supplier
    rat anti‐ng2  (Thermo Fisher)
    90
    Thermo Fisher rat anti‐ng2
    Anti‐PD‐L1 treatment elicits increased intramucosal T‐cell infiltration and decreased blood vascular density with proper pericyte coverage. Mice were submucosally injected with 5 × 10 5 AOC3‐LN cells in the left buccal area and intraperitoneally injected with an anti‐PD‐L1 inhibitor (10 mg·kg −1 ) twice a week for 3 weeks. (A–D) Immunofluorescence images showing CD8: representing T‐cells, CD31: representing blood vessels, <t>NG2:</t> representing pericyte coverages, and GLUT1: representing hypoxic condition expression level in the tumor microenvironment. Scale bars, 100 μm. (E–H) Comparisons of CD8: representing T‐cells, CD31: representing blood vessels, NG2: representing pericyte coverages, and GLUT1: representing hypoxic condition expression level between control and anti‐PD‐1‐treated groups; Values are expressed as means ± SD, n = 6 in Control, n = 6 in PD‐L1; Student's T tests were performed between groups and * P < 0.05 versus control. (I) Intratumor VEGF levels were assessed using an ELISA kit; Values are expressed as means ± SD, n = 6 in Control, n = 6 in PD‐L1; Student's T tests were performed between groups and * P < 0.05 versus control. Representative results obtained from three repetitive experiments with the same number of mice. ELISA, enzyme‐linked immunosorbent assay; LN, lymph node; PD, programmed death; VEGF, vascular endothelial growth factor receptor.
    Rat Anti‐Ng2, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rat anti‐ng2/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    rat anti‐ng2 - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    rat anti ng2  (Thermo Fisher)
    86
    Thermo Fisher rat anti ng2
    Anti‐PD‐L1 treatment elicits increased intramucosal T‐cell infiltration and decreased blood vascular density with proper pericyte coverage. Mice were submucosally injected with 5 × 10 5 AOC3‐LN cells in the left buccal area and intraperitoneally injected with an anti‐PD‐L1 inhibitor (10 mg·kg −1 ) twice a week for 3 weeks. (A–D) Immunofluorescence images showing CD8: representing T‐cells, CD31: representing blood vessels, <t>NG2:</t> representing pericyte coverages, and GLUT1: representing hypoxic condition expression level in the tumor microenvironment. Scale bars, 100 μm. (E–H) Comparisons of CD8: representing T‐cells, CD31: representing blood vessels, NG2: representing pericyte coverages, and GLUT1: representing hypoxic condition expression level between control and anti‐PD‐1‐treated groups; Values are expressed as means ± SD, n = 6 in Control, n = 6 in PD‐L1; Student's T tests were performed between groups and * P < 0.05 versus control. (I) Intratumor VEGF levels were assessed using an ELISA kit; Values are expressed as means ± SD, n = 6 in Control, n = 6 in PD‐L1; Student's T tests were performed between groups and * P < 0.05 versus control. Representative results obtained from three repetitive experiments with the same number of mice. ELISA, enzyme‐linked immunosorbent assay; LN, lymph node; PD, programmed death; VEGF, vascular endothelial growth factor receptor.
    Rat Anti Ng2, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rat anti ng2/product/Thermo Fisher
    Average 86 stars, based on 1 article reviews
    rat anti ng2 - by Bioz Stars, 2026-03
    86/100 stars
    		  Buy from Supplier
    rat anti-ng2  (Thermo Fisher)
    90
    Thermo Fisher rat anti-ng2
    Anti‐PD‐L1 treatment elicits increased intramucosal T‐cell infiltration and decreased blood vascular density with proper pericyte coverage. Mice were submucosally injected with 5 × 10 5 AOC3‐LN cells in the left buccal area and intraperitoneally injected with an anti‐PD‐L1 inhibitor (10 mg·kg −1 ) twice a week for 3 weeks. (A–D) Immunofluorescence images showing CD8: representing T‐cells, CD31: representing blood vessels, <t>NG2:</t> representing pericyte coverages, and GLUT1: representing hypoxic condition expression level in the tumor microenvironment. Scale bars, 100 μm. (E–H) Comparisons of CD8: representing T‐cells, CD31: representing blood vessels, NG2: representing pericyte coverages, and GLUT1: representing hypoxic condition expression level between control and anti‐PD‐1‐treated groups; Values are expressed as means ± SD, n = 6 in Control, n = 6 in PD‐L1; Student's T tests were performed between groups and * P < 0.05 versus control. (I) Intratumor VEGF levels were assessed using an ELISA kit; Values are expressed as means ± SD, n = 6 in Control, n = 6 in PD‐L1; Student's T tests were performed between groups and * P < 0.05 versus control. Representative results obtained from three repetitive experiments with the same number of mice. ELISA, enzyme‐linked immunosorbent assay; LN, lymph node; PD, programmed death; VEGF, vascular endothelial growth factor receptor.
    Rat Anti Ng2, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rat anti-ng2/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    rat anti-ng2 - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    rat anti-nidogen (ng2)  (Thermo Fisher)
    90
    Thermo Fisher rat anti-nidogen (ng2)
    Anti‐PD‐L1 treatment elicits increased intramucosal T‐cell infiltration and decreased blood vascular density with proper pericyte coverage. Mice were submucosally injected with 5 × 10 5 AOC3‐LN cells in the left buccal area and intraperitoneally injected with an anti‐PD‐L1 inhibitor (10 mg·kg −1 ) twice a week for 3 weeks. (A–D) Immunofluorescence images showing CD8: representing T‐cells, CD31: representing blood vessels, <t>NG2:</t> representing pericyte coverages, and GLUT1: representing hypoxic condition expression level in the tumor microenvironment. Scale bars, 100 μm. (E–H) Comparisons of CD8: representing T‐cells, CD31: representing blood vessels, NG2: representing pericyte coverages, and GLUT1: representing hypoxic condition expression level between control and anti‐PD‐1‐treated groups; Values are expressed as means ± SD, n = 6 in Control, n = 6 in PD‐L1; Student's T tests were performed between groups and * P < 0.05 versus control. (I) Intratumor VEGF levels were assessed using an ELISA kit; Values are expressed as means ± SD, n = 6 in Control, n = 6 in PD‐L1; Student's T tests were performed between groups and * P < 0.05 versus control. Representative results obtained from three repetitive experiments with the same number of mice. ELISA, enzyme‐linked immunosorbent assay; LN, lymph node; PD, programmed death; VEGF, vascular endothelial growth factor receptor.
    Rat Anti Nidogen (Ng2), supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rat anti-nidogen (ng2)/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    rat anti-nidogen (ng2) - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    mouse anti rat a sma  (Proteintech)
    94
    Proteintech mouse anti rat a sma
    Anti‐PD‐L1 treatment elicits increased intramucosal T‐cell infiltration and decreased blood vascular density with proper pericyte coverage. Mice were submucosally injected with 5 × 10 5 AOC3‐LN cells in the left buccal area and intraperitoneally injected with an anti‐PD‐L1 inhibitor (10 mg·kg −1 ) twice a week for 3 weeks. (A–D) Immunofluorescence images showing CD8: representing T‐cells, CD31: representing blood vessels, <t>NG2:</t> representing pericyte coverages, and GLUT1: representing hypoxic condition expression level in the tumor microenvironment. Scale bars, 100 μm. (E–H) Comparisons of CD8: representing T‐cells, CD31: representing blood vessels, NG2: representing pericyte coverages, and GLUT1: representing hypoxic condition expression level between control and anti‐PD‐1‐treated groups; Values are expressed as means ± SD, n = 6 in Control, n = 6 in PD‐L1; Student's T tests were performed between groups and * P < 0.05 versus control. (I) Intratumor VEGF levels were assessed using an ELISA kit; Values are expressed as means ± SD, n = 6 in Control, n = 6 in PD‐L1; Student's T tests were performed between groups and * P < 0.05 versus control. Representative results obtained from three repetitive experiments with the same number of mice. ELISA, enzyme‐linked immunosorbent assay; LN, lymph node; PD, programmed death; VEGF, vascular endothelial growth factor receptor.
    Mouse Anti Rat A Sma, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse anti rat a sma/product/Proteintech
    Average 94 stars, based on 1 article reviews
    mouse anti rat a sma - by Bioz Stars, 2026-03
    94/100 stars
    		  Buy from Supplier

    Image Search Results


    Anti‐PD‐L1 treatment elicits increased intramucosal T‐cell infiltration and decreased blood vascular density with proper pericyte coverage. Mice were submucosally injected with 5 × 10 5 AOC3‐LN cells in the left buccal area and intraperitoneally injected with an anti‐PD‐L1 inhibitor (10 mg·kg −1 ) twice a week for 3 weeks. (A–D) Immunofluorescence images showing CD8: representing T‐cells, CD31: representing blood vessels, NG2: representing pericyte coverages, and GLUT1: representing hypoxic condition expression level in the tumor microenvironment. Scale bars, 100 μm. (E–H) Comparisons of CD8: representing T‐cells, CD31: representing blood vessels, NG2: representing pericyte coverages, and GLUT1: representing hypoxic condition expression level between control and anti‐PD‐1‐treated groups; Values are expressed as means ± SD, n = 6 in Control, n = 6 in PD‐L1; Student's T tests were performed between groups and * P < 0.05 versus control. (I) Intratumor VEGF levels were assessed using an ELISA kit; Values are expressed as means ± SD, n = 6 in Control, n = 6 in PD‐L1; Student's T tests were performed between groups and * P < 0.05 versus control. Representative results obtained from three repetitive experiments with the same number of mice. ELISA, enzyme‐linked immunosorbent assay; LN, lymph node; PD, programmed death; VEGF, vascular endothelial growth factor receptor.

    Journal: Molecular Oncology

    Article Title: Immune checkpoint inhibitor monotherapy is sufficient to promote microenvironmental normalization via the type I interferon pathway in PD‐L1 ‐expressing head and neck cancer

    doi: 10.1002/1878-0261.13633

    Figure Lengend Snippet: Anti‐PD‐L1 treatment elicits increased intramucosal T‐cell infiltration and decreased blood vascular density with proper pericyte coverage. Mice were submucosally injected with 5 × 10 5 AOC3‐LN cells in the left buccal area and intraperitoneally injected with an anti‐PD‐L1 inhibitor (10 mg·kg −1 ) twice a week for 3 weeks. (A–D) Immunofluorescence images showing CD8: representing T‐cells, CD31: representing blood vessels, NG2: representing pericyte coverages, and GLUT1: representing hypoxic condition expression level in the tumor microenvironment. Scale bars, 100 μm. (E–H) Comparisons of CD8: representing T‐cells, CD31: representing blood vessels, NG2: representing pericyte coverages, and GLUT1: representing hypoxic condition expression level between control and anti‐PD‐1‐treated groups; Values are expressed as means ± SD, n = 6 in Control, n = 6 in PD‐L1; Student's T tests were performed between groups and * P < 0.05 versus control. (I) Intratumor VEGF levels were assessed using an ELISA kit; Values are expressed as means ± SD, n = 6 in Control, n = 6 in PD‐L1; Student's T tests were performed between groups and * P < 0.05 versus control. Representative results obtained from three repetitive experiments with the same number of mice. ELISA, enzyme‐linked immunosorbent assay; LN, lymph node; PD, programmed death; VEGF, vascular endothelial growth factor receptor.

    Article Snippet: Subsequently, the tissue sections were blocked with 5% goat serum in PBST (0.1% Triton X‐100 in PBS) and incubated for 3 h at room temperature with the following primary antibodies: hamster anti‐CD31 (clone 2H8; Millipore, Burlington, MA, USA), rabbit anti‐PD‐L1 (clone 28‐8; BD Biosciences, San Jose, CA, USA), hamster anti‐CD3e (clone 145‐2C11; BD Biosciences), rat anti‐CD8 (clone 53‐6.7; BD Biosciences), rat anti‐CD4 (clone RM4‐5; eBioscience, San Diego, CA, USA), rat anti‐F4/80 (clone BM8; eBioscience), rat anti‐Ly6G (clone 1A8; BD Biosciences), rat anti‐NG2 (clone 546 930; Invitrogen, Carlsbad, CA, USA), rabbit anti‐GLUT1 (clone SA0377; Invitrogen).

    Techniques: Injection, Immunofluorescence, Expressing, Control, Enzyme-linked Immunosorbent Assay